{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:24:51Z","timestamp":1790807091990,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10549-019-05168-1","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T03:44:21Z","timestamp":1550807061000},"page":"479-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors"],"prefix":"10.1007","volume":"175","author":[{"given":"Gitana Maria","family":"Aceto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Dafaallah","family":"Awadelkarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Di Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Moscatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia Russel","family":"Pantalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Verginelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasr Eldin","family":"Elwali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-1848","authenticated-orcid":false,"given":"Renato","family":"Mariani-Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"issue":"23","key":"5168_CR1","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1002\/cncr.30248","volume":"122","author":"PL Mai","year":"2016","unstructured":"Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA (2016) Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer 122(23):3673\u20133681","journal-title":"Cancer"},{"issue":"1","key":"5168_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","volume":"30","author":"A Amadou","year":"2018","unstructured":"Amadou A, Waddington Achatz MI, Hainaut P (2018) Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. Curr Opin Oncol 30(1):23\u201329","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"5168_CR3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ejca.2005.11.032","volume":"42","author":"F Lalloo","year":"2006","unstructured":"Lalloo F, Varley J, Moran A, Ellis D, O\u2019dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42(8):1143\u20131150","journal-title":"Eur J Cancer"},{"issue":"12","key":"5168_CR4","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","volume":"70","author":"J Mouchawar","year":"2010","unstructured":"Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC (2010) Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian breast cancer family study. Cancer Res 70(12):4795\u20134800","journal-title":"Cancer Res"},{"issue":"3","key":"5168_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3322\/canjclin.41.3.146","volume":"41","author":"JL Kelsey","year":"1991","unstructured":"Kelsey JL, Gammon MD (1991) The epidemiology of breast cancer. CA Cancer J Clin 41(3):146\u2013165","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"5168_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2559.2008.02966.x","volume":"52","author":"KD Awadelkarim","year":"2008","unstructured":"Awadelkarim KD, Arizzi C, Elamin EO, Hamad HM, De Blasio P, Mekki SO, Osman I, Biunno I, Elwali NE, Mariani-Costantini R et al (2008) Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 52(4):445\u2013456","journal-title":"Histopathology"},{"issue":"4","key":"5168_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrclinonc.2013.38","volume":"10","author":"R Mariani-Costantini","year":"2013","unstructured":"Mariani-Costantini R (2013) Diagnosis: breast cancer screening in rural African communities. Nat Rev Clin Oncol 10(4):185\u2013186","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"5168_CR8","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1016\/S2214-109X(16)30259-5","volume":"4","author":"E Jedy-Agba","year":"2016","unstructured":"Jedy-Agba E, McCormack V, Adebamowo C, Dos-Santos-Silva I (2016) Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 4(12):e923\u2013e935","journal-title":"Lancet Glob Health"},{"key":"5168_CR9","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1017\/gheg.2018.8","volume":"3","author":"A Abbad","year":"2018","unstructured":"Abbad A, Baba H, Dehbi H, Elmessaoudi-Idrissi M, Elyazghi Z, Abidi O, Radouani F (2018) Genetics of breast cancer in African populations: a literature review. Glob Health Epidemiol Genom 3:e8","journal-title":"Glob Health Epidemiol Genom"},{"issue":"4","key":"5168_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10689-018-0075-5","volume":"17","author":"S Macaulay","year":"2018","unstructured":"Macaulay S, Goodyear QC, Kruger M, Chen W, Essop F, Krause A (2018) The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome. Fam Cancer 17(4):607\u2013613","journal-title":"Fam Cancer"},{"issue":"2","key":"5168_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-006-9303-z","volume":"102","author":"KD Awadelkarim","year":"2007","unstructured":"Awadelkarim KD, Aceto G, Veschi S, Elhaj A, Morgano A, Mohamedani AA, Eltayeb EA, Abuidris D, Di Gioacchino M, Battista P et al (2007) BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat 102(2):189\u2013199","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5168_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10689-014-9717-4","volume":"13","author":"I Biunno","year":"2014","unstructured":"Biunno I, Aceto G, Awadelkarim KD, Morgano A, Elhaj A, Eltayeb EA, Abuidris DO, Elwali NE, Spinelli C, De Blasio P et al (2014) BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan. Fam Cancer 13(3):437\u2013444","journal-title":"Fam Cancer"},{"key":"5168_CR13","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division (2017). World Fertility Data 2017 (POP\/DB\/Fert\/Rev2017)"},{"issue":"37","key":"5168_CR14","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/sj.onc.1203758","volume":"19","author":"SJ Verselis","year":"2000","unstructured":"Verselis SJ, Rheinwald JG, Fraumeni JF, Li FP (2000) Novel p53 splice site mutations in three families with Li-Fraumeni syndrome. Oncogene 19(37):4230\u20134235","journal-title":"Oncogene"},{"issue":"6","key":"5168_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28(6):622\u2013629","journal-title":"Hum Mutat"},{"issue":"7311","key":"5168_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature09298","volume":"467","author":"DM Altshuler","year":"2010","unstructured":"Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Bonnen PE, de Bakker PI, Deloukas P, Gabriel SB et al (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467(7311):52\u201358","journal-title":"Nature"},{"key":"5168_CR17","unstructured":"Sudan Nutrition Profile (2005) Food and Nutrition Division, Food and Agriculture Organization of the United Nations"},{"issue":"9","key":"5168_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ng1416","volume":"36","author":"AJ Iafrate","year":"2004","unstructured":"Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C (2004) Detection of large-scale variation in the human genome. Nat Genet 36(9):949\u2013951","journal-title":"Nat Genet"},{"issue":"1\u20132","key":"5168_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.exger.2004.10.001","volume":"40","author":"D Heemst van","year":"2005","unstructured":"van Heemst D, Mooijaart SP, Beekman M, Schreuder J, de Craen AJ, Brandt BW, Slagboom PE, Westendorp RG (2005) group LLs: variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 40(1\u20132):11\u201315","journal-title":"Exp Gerontol"},{"issue":"2","key":"5168_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrc2584","volume":"9","author":"C Whibley","year":"2009","unstructured":"Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev Cancer 9(2):95\u2013107","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"5168_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng1093","volume":"33","author":"P Dumont","year":"2003","unstructured":"Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33(3):357\u2013365","journal-title":"Nat Genet"},{"issue":"5","key":"5168_CR22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1096\/fj.09-146001","volume":"24","author":"BS Jeong","year":"2010","unstructured":"Jeong BS, Hu W, Belyi V, Rabadan R, Levine AJ (2010) Differential levels of transcription of p53-regulated genes by the arginine\/proline polymorphism: p53 with arginine at codon 72 favors apoptosis. FASEB J 24(5):1347\u20131353","journal-title":"FASEB J"},{"issue":"3","key":"5168_CR23","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/bcr1682","volume":"9","author":"T Toyama","year":"2007","unstructured":"Toyama T, Zhang Z, Nishio M, Hamaguchi M, Kondo N, Iwase H, Iwata H, Takahashi S, Yamashita H, Fujii Y (2007) Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Res 9(3):R34","journal-title":"Breast Cancer Res"},{"issue":"3\u20134","key":"5168_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1101\/gad.309062.117","volume":"32","author":"S Basu","year":"2018","unstructured":"Basu S, Gnanapradeepan K, Barnoud T, Kung CP, Tavecchio M, Scott J, Watters A, Chen Q, Kossenkov AV, Murphy ME (2018) Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1\u03b1. Genes Dev 32(3\u20134):230\u2013243","journal-title":"Genes Dev"},{"key":"5168_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fonc.2015.00277","volume":"5","author":"JS Lawson","year":"2015","unstructured":"Lawson JS, Glenn WK, Salyakina D, Delprado W, Clay R, Antonsson A, Heng B, Miyauchi S, Tran DD, Ngan CC et al (2015) Human Papilloma viruses and breast cancer. Front Oncol 5:277","journal-title":"Front Oncol"},{"issue":"12","key":"5168_CR26","doi-asserted-by":"publisher","first-page":"10833","DOI":"10.1007\/s11033-012-1978-0","volume":"39","author":"HA Eltahir","year":"2012","unstructured":"Eltahir HA, Adam AA, Yahia ZA, Ali NF, Mursi DM, Higazi AM, Eid NA, Elhassan AM, Mohammed HS, Ibrahim ME (2012) p53 codon 72 arginine\/proline polymorphism and cancer in Sudan. Mol Biol Rep 39(12):10833\u201310836","journal-title":"Mol Biol Rep"},{"key":"5168_CR27","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1038\/cddis.2013.24","volume":"4","author":"C Sagne","year":"2013","unstructured":"Sagne C, Marcel V, Amadou A, Hainaut P, Olivier M, Hall J (2013) A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects. Cell Death Dis 4:e492","journal-title":"Cell Death Dis"},{"issue":"4","key":"5168_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/A:1015287208222","volume":"13","author":"Q Liu","year":"2002","unstructured":"Liu Q, Wuu J, Lambe M, Hsieh SF, Ekbom A, Hsieh CC (2002) Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 13(4):299\u2013305","journal-title":"Cancer Causes Control"},{"issue":"10","key":"5168_CR29","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-09-3450","volume":"70","author":"ES D\u00edaz-Cruz","year":"2010","unstructured":"D\u00edaz-Cruz ES, Furth PA (2010) Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res 70(10):3965\u20133974","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05168-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T19:16:05Z","timestamp":1582312565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05168-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5168"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05168-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"5 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Ethical Committees of the National Cancer Institute, University of Gezira (NCI-UG) and \u201cG. d\u2019Annunzio\u201d University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}